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ABSTRACT 
  
 
 
Recent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin 
and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, 
and should be carefully reviewed concerning the potential presence of irritant con- stituents. In particular, cosmetic products used on the face, in vicinity of 
the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In 
this study, we aimed to evaluate the effect of a new cosmetic ingredi- ent, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using 
reconstructed human epidermis, EpiSkinTM, and human corneal epithelial model, SkinEthicsTM HCE, and an in vivo assay. Three different extracts of CS were 
evaluated. The histology of the models after extracts applica- tions was analysed. The in vitro results demonstrated that extracts were not classiﬁed as irritant and the 
histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantiﬁed 
after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can 
be regarded as safe for topical  application. 
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1. Introduction 
 
In recent years, sustainable approaches have become an essen- tial 
challenge for different industries. Answering to this issue, the present 
study was undertaken to investigate the potential use of coffee 
silverskin (CS) extracts in cosmetic products. Usually, per coffee fruit 
are found two coffee beans, each one covered by a thin closely skin 
called silverskin (Saenger et al., 2001). CS is a main by- product of the 
coffee roasting procedure and has no commercial value, being 
discarded as a solid waste (Saenger et al., 2001). This 
 
 
 
 
may have negative effects on the environment requiring proper 
management. Recent advances in industrial biotechnology leads to 
potential opportunities for economic valorization of this by- product 
(Pandey et al., 2000). Some work has been performed on the 
properties of CS, in particular its antioxidant behaviour, which reveals 
a good content (Borrelli et al., 2004; Costa et al., 2014; Narita and 
Inouye, 2012; Panusa et al., 2013; Pourfarzad et al., 2013; 
Rodrigues et al., 2015). An example is chlorogenic acid (CGA), which 
is a highly valuable natural polyphenol com- pound used in medicine 
and industries (Sato et al., 2011). However, some process steps in coffee 
production could affect CGA content, such as roasting, decaffeination 
and/or blending (Mills et al., 2013). Also, the caffeine content should be 
very high and similar to that of coffee beans (Bresciani et al., 2014; 
Narita and Inouye, 2012; 
 
  
 
Pourfarzad et al., 2013). These compounds are believed to provide in 
vivo protection against free radical damage. As coffee beans, CS 
contains several classes of health compounds such as phenolics, 
diterpenes, xanthines, and vitamin precursors (Alves et al., 2009; 
Ludwig et al., 2012). Caffeine is being increasingly used in cos- metics 
due to its high biological activity and ability to penetrate the skin 
barrier (Herman and Herman, 2013). A number of claims, as anti-
cellulite properties, are based on the implicit assumption that this 
bioactive substance is effectively released from the for- mulation into 
epidermis and probably through epidermis into the dermal and 
subcutaneous tissues, preventing the excessive accu- mulation of fat in 
cells, and providing a slimming effect (Bolzinger et al., 2008; Herman 
and Herman, 2013). This alkaloid stimulates the degradation of fats 
during lipolysis through inhibition of the phosphodiesterase activity 
and has potent antioxidant properties (Herman and Herman, 2013). 
However, studies assessing the skin absorption of caffeine released 
from extracts are extremely rare in the literature. Another compound 
that should be taken in con- sideration regarding CS is 5-hydroxymethyl 
furfural (HMF), which is formed during coffee roasting (del Campo et 
al., 2010). HMF is cytotoxic, irritating to the eyes, skin and mucous 
membranes at high concentrations, being very important to quantify 
its presence in CS extracts (Capuano and Fogliano, 2011). 
The assessment of irritation is one of the primary procedures to 
evaluate and hazard classify a substance, particularly, in cosmet- ics or 
pharmaceuticals (Cotovio et al., 2010). In line with the  7th 
amendment deadlines, European Union bans the in vivo skin irri- 
Deionised water was obtained using Mili-Q water puriﬁcation sys- tem 
(TGI Pure Water Systems, USA). Ethanol was obtained from Panreac 
(Barcelona, Spain). HPLC-grade acetonitrile was from Fluka (Madrid, 
Spain). 5-(Hydroxymethyl)furfural (HMF), caffeine and chlorogenic acid 
(CGA) standards were from Sigma–Aldrich (Stein- heim, Germany). 
Metaphosphoric acid, isopropanol, phosphate buffered saline (PBS; pH 
7.4) and paraformaldehyde were from Sigma–Aldrich (St. Louis, Missouri, 
USA). 
 
2.2. Preparation of extracts 
 
CS was milled to particle size of approximately 0.1 mm using a A11 
basic analysis mill (IKA Wearke, Staufen, Germany) and stored in silicone 
tubes at room temperature (25–28 ◦C) until extract preparation, as 
described by different authors (Costa et al., 2014; Rodrigues et al., 
2015). Samples (1 g) were submitted to solvent extraction by 
maceration with 20 mL of water, ethanol:water (1:1, v/v) or ethanol 
for 30 min at 40 ◦C. The three different extracts obtained were ﬁltered 
through Whatman No. 1 paper ﬁlter and the ﬁltrates collected (Costa et 
al., 2014). 
 
2.3. In vitro models assays 
 
In order to determine the irritant potential of CS extracts on skin 
and eye, in vitro tests were performed. Three different extracts 
mentioned  above  were tested. 
TM 
tation assessment on ingredients for cosmetic purposes, regarding The EpiSkin model (large model) was obtained from a stan- 
concerns about the test’s reproducibility, plus animal welfare and dardized large-scale production certiﬁed by the ISO 9001 standard. TM 
political pressures (Draize et al., 1944; Spielmann et al., 2007).  A EpiSkin units were delivered to the laboratory within 24 h. 
number of in vitro tests to assess potential skin or eye irritants have 
been developed. The reconstructed human epidermis EpiSkinTM test 
method was validated by European Union Reference Labora- 
Upon arrival, tissues were transferred to 12 well plates containing 37 ◦C 
pre-warmed maintenance media (2 mL/well) and incubated overnight at 
37 ◦C, 5% CO2 and 95% relative humidity. TM 
tory for alternatives to animal testing (ECVAM) as replacement test The  SkinEthic HCE  model   is   composed   of immortalized 
for the prediction of acute skin irritation. According to Cotovio et al. 
(2010), the assessment of ocular irritation is also one of the primary 
procedures to evaluate and hazard classify a new substance. The in 
vivo Draize irritation rabbit eye test continues to be described in the 
current OECD test guidelines, but ethical questions are lead- ing to the 
development of in vitro alternative tests, such as Human Corneal 
Epithelial Model (SkinEthicTM HCE), which are still under validation by 
ECVAM. 
The aim of this study is to evaluate the in vitro and in vivo irrita- tion 
potential of three CS extracts. For both EpiSkinTM and SkinEthic HCETM 
assays, MTT and IL-1a were used as endpoints. After the extract 
contact with the model, the histology of the model was eval- uated. To 
ensure the possible content of caffeine, CQA and HMF that pass through 
RhE, an HPLC assay was developed. In vivo skin irri- tation potential 
observed after single application under occlusion was assessed along 
with sodium lauryl sulfate (SLS) solution (2%, w/v) as irritant model 
(positive control) and water as non-irritant (negative control). 
 
 
2. Materials and methods 
 
2.1. Chemicals 
 
Coffee  silverskin  samples  were  provided  by  a  national  coffee 
roaster  (BICAFÉ  –  Torrefac¸ ão  e  Comércio  de  Café  Lda,  Portugal). 
EpiSkinTM    and   SkinEthicTM    HCE   model   were   purchased   from 
SkinEthic  Laboratories  (Lyon,  France).  3-[4,5-Dimethylthiazol-2- yl]-
2,5-diphenyltetrazolium  bromide  (MTT)  and  sodium  lauryl sulfate  
(SLS;  purity  >99%)  were  purchased  from  Sigma–Aldrich Chemical   (St   
Quentin   Fallavier,   France).   ELISA   Quantikin   kit for  IL-1a  
measurements  was  from  R&D  Systems  (Lille,  France). 
human corneal epithelial cells cultured in a chemically    deﬁned 
medium and seeded on a synthetic membrane at the air–liquid 
interface. The tissue is represented by a multilayered epithelium, with 
ﬁve to seven cell layers and a surface area of 0.5 cm2. The assay was 
performed according to the manufacturer instructions (Alépée et al., 
2013; Cotovio et al., 2010). Upon arrival, tissues were 
transferred to 24 well plates containing 37 ◦C pre-warmed mainte- 
nance media (1 mL/well) and incubated 24 h at 37 ◦C, 5% CO2 and 95% 
relative humidity. 
 
2.3.1. Skin irritation test 
The in vitro reconstructed human skin tissue (EpiSkinTM) method, 
proposed to replace animal testing for skin corrosivity and skin irritation 
(Tornier et al., 2010), is based on determining cell via- bility, and cytokine 
release (IL-1a) as an additional endpoint. The reconstructed 0.38 cm2 
skin inserts were used and the assay was performed according to the 
manufacturer instructions and proto- col. Negative (PBS-treated) and 
positive controls (5% (w/v) of SLS) were used. After exposing to the 
extracts and controls for 15 min, the epidermis samples were washed 
with sterile PBS and then incu- 
bated in the maintenance medium. After 42 h, the medium was 
collected and frozen at −20 ◦C for further determination of IL-1a. Cell 
viability was determined by the MTT assay. Viability was cal- culated, 
considering 100% for the negative control. The histology of 
models was also evaluated as described below. 
 
2.3.2. Ocular irritation test 
The SkinEthicTM HCE model was used and the assay performed 
according to the manufacturer instructions and protocol. Nega- tive 
(PBS-treated) and positive controls (ethanol) were used. After exposing 
to the extracts and controls for 10 min, the epidermis samples were 
washed with sterile PBS and then incubated in the 
  
 
maintenance medium for 16 h. After this time, the medium was col- 
lected and frozen at −20 ◦C for further determination of IL-1a, and the 
cell viability was determined by the MTT assay. Viability was 
calculated, considering 100% for the negative control. The model was 
also analysed regarding the histological aspects. 
 
2.3.3. MTT assay 
Immediately after rinsing, the tissues were evaluated for cell via- bility 
using the MTT assay, where yellow MTT is reduced to purple formazan 
primarily by enzymes (reductases) located in the mito- chondria of 
living cells. A stock solution of MTT was prepared in 
maintenance media (provided with tissues) just prior to use and 
warmed to 37 ◦C in a water bath. Tissues were transferred to 24- 
well plates (Corning Inc., Corning, New York) containing 300 µL MTT 
medium per well and placed in the 37 ◦C, 5% CO2 humidiﬁed incubator. 
After 3 h incubation, the tissues were removed from the MTT medium 
and any residual MTT media on the exterior of the tis- sue insert was 
blotted with absorbent pads. The formazan salt was extracted from the 
tissues by transferring them to 24-well plates containing isopropanol. 
The submerged tissues were incubated 3 h at room temperature 
protected from light. The plates were shaken for approximately 15 min 
once the extraction was complete. The optical density of the extracted 
formazan was determined by trans- ferring 200 µL of each extraction 
solution into a clean 96-well plate. Isopropanol was used as a blank. 
The plates were read using a spectrophotometer (Synergy HT 
Microplate Reader; BioTek Instru- ments, Inc., Winooski, VT, USA) at 570 
nm. Relative cell viability was calculated for each tissue as percent of 
the mean of the negative control tissues. 
For both models, if the percentage of viability was >50%, the sub- 
stance was predicted as Non-Irritant (EU classiﬁcation: no label; GHS 
classiﬁcation: No category); if the percentage of viability was 
≤50%, the substance was predicted as Irritant (EU classiﬁcation: 
R38, R41 or R36, depending on the model; GSH classiﬁcation: Cat- egory 
1 or Category 2) (Cotovio et al., 2010). 
 
2.3.4. IL-1˛ assay 
For assessing the release of IL-1a, the culture media underneath the 
tissues were collected at the end of the post-incubation period and 
kept at −20 ◦C until measurement. The quantiﬁcation of IL-1a 
was performed using the commercial enzyme-linked immunosor- 
bent assay (ELISA) kit Quantikine® DLA50 (R&D Systems, UK) according to 
the manufacturer’s instructions. Mean concentrations (pg/mL) were 
obtained using duplicate measurements per tissue. IL-1a  released was 
expressed as absolute  data. 
 
2.3.5. Histology 
After incubating in the presence of CS extracts, EpiSkinTM and 
SkinEthicTM HCE samples (three samples per extract) were ﬁxed with 
2% paraformaldehyde during 1 h and embedded in Richard-Allan 
ScientiﬁcTM Neg-50TM Frozen Section Medium (ThermoScientiﬁcTM) 
before cryosections (7 µm) preparation (Microm HM550 cryostat; 
ThermoScientiﬁcTM). Samples were stained with haematoxylin–eosin–
safran (H&S), and epidermal thickness was measured using image 
analysis with Axiovision software (Zeiss, Sartrouville, France). Each 
image was studied for changes to the epidermis and especially to cell 
morphology. 
 
2.4. Analysis of caffeine, HMF and CGA content in EpiSkinTM 
 
The HPLC method used in this study to quantify HMF, CQA and caffeine 
in CS extracts was based on the work of Lemos et al. (2010) and Rivelli et 
al. (2007). The chromatographic analysis was per- formed in a HPLC 
integrated system (Jasco, Japan) equipped with a PU-980 pump and a 
Jasco AS-950 automatic sampler with a 20 µL 
 
loop. Detection was performed with a Jasco model MD-2010 mul- 
tiwavelength diode-array detector (DAD). The column employed was a 
Luna 5U C18 (5 µm, 150 mm × 4.60 mm) chromatographic column 
(Teknokroma, Spain). The mobile phase adopted was aque- ous 
metaphosphoric acid solution:acetonitrile (82:18, v/v) with a ﬂow rate 
of 1 mL/min and a column temperature of 23 ◦C. Analytes were 
monitored at 275 nm, 285 nm and 330 nm, respectively, for caffeine, 
HMF and CGA, and quantiﬁcation was performed on the basis of the 
internal standard method. Chromatographic data were analysed using 
the ChromNAV Software (Jasco, Japan). Calibra- tion curves were 
prepared for HMF (0.36–93.0 mg/mL), chlorogenic acid (5.0–160.0 
mg/mL) and caffeine (4.25–136.0 mg/mL). Analyses were carried out in 
duplicate. Conﬁrmation of compounds identi- ties was performed by 
comparing retention times and co-elution with authentic standards 
and also by UV absorption spectra. 
 
2.5. In vivo skin irritation 
 
2.5.1. Patch test 
A single blinded study was done in order to evaluate the in vivo skin 
irritation. Twenty healthy individuals (15 women and 5 men) with a 
mean age of 30 ± 5 years, without known dermatological dis- eases or 
allergy to substances in topical products, participated in a blind study, in 
accordance with Declaration of Helsinki. Informed consent was 
obtained from all volunteers. The volunteers were asked to not apply 
any topical products in the forearms 24 h before the beginning and 
throughout the test period. Additionally, solar exposure was forbidden. 
Along with extracts, SLS (2%, w/v, aque- ous solution) and puriﬁed 
water were also assayed, respectively, as positive and negative 
control. Five sites were marked in the inner forearms of volunteers. 
Before application of patch tests, the areas on the ventral part of 
each forearm were marked using a skin marker, and basal values 
were obtained by non-invasive measuring method. After basal 
measures were taken, the patches were applied. Fifty microlitres of 
the test solutions were applied on a ﬁlter paper disc (12 mm, Filter 
Paper Discs,   SmartPractice, 
Phoenix, USA) and occlusion was achieved with aluminium cham- bers 
(12 mm, Finn Chambers, SmartPractice, Phoenix, USA). Patches were 
removed after 48 h, and following a period of 2 h of observa- tion patch 
test areas were evaluated by non-invasive measuring methods and 
visual scoring. 
 
2.5.2. Visual and instrumental assessments 
The visual assessment of the degree of irritation was graded 
according to the following scale, previously used by Agner et al. 
(2000): 0 – no reaction; 1 – weak, spotty erythema; 2 – well per- 
ceptible erythema covering the total exposure area; 3 – moderate 
erythema or severe erythema that covers the total exposure area. The 
same scale was used for oedema: 0 – no reaction; 1 – weak, spotty 
oedema; 2 – well perceptible oedema covering the total exposure 
area; 3 – moderate or severe oedema that covers the total exposure 
area (Agner et al., 2000). 
Non-invasive biophysical measurements were also performed. All 
measurements  were  made  with  controlled temperature (21–22 ◦C) 
and relative humidity (45–55%). Transepidermal    water 
loss (TEWL) is traditionally used to assess skin barrier function (Wa 
and Maibach, 2010). Barrier function was evaluated by TEWL 
measurements, carried out with a Tewameter® TM 210 (Courage 
Khazaka, Electronic GmbH, Cologne, Germany), which measures the 
relative humidity percentage which diffuses from the dermis to the 
skin surface (g/cm2 h). 
 
2.6. Statistical analysis 
 
Data were reported as mean ± standard deviation of at least trip- licate 
experiments. Statistical analysis of the results was performed 
  
 
Table 1 
EpiSkinTM tissues were exposed for 15 min to controls and extracts. Cell viability was 
assessed by MTT while the post-exposure basal media was analysed for IL-1a release 
(pg/mL). 
Table 2 
Quantiﬁcation of HMF, CGA and CAF in aqueous (W), hydro-alcoholic (WA) and alcoholic 
(A) extracts of CS medium after EpiSkinTM    assay. 
 
 
 
 
 
PC (SLS) 11.6  ± 2.4b 522.9  ± 32.1c 
    NC (PBS) 100  ± 9.7a 28.4 ± 2.6a,b   
 
Values are expressed as mean ± 
* 
 
SD (n = 3). 
 
Water (W), hydro-alcoholic (WA) mixture, alcohol (A), a positive control (PC: SLS – sodium 
lauryl sulfate) and a negative control (NC: PBS – phosphate buffered saline) were used. 
Values are expressed as mean ± SD (n = 3). Values in the same column followed by 
different letters indicate signiﬁcant differences (p < 0.05). 
 
 
 
with the software SPSS 22.0 (SPSS Inc., Chicago, IL, USA). One-way 
ANOVA was used to investigate the differences between differ- ent 
extracts for all assays. Post hoc comparisons were performed 
according to Tukey’s HSD test. In all cases, p < 0.05 was accepted as 
denoting signiﬁcance. 
 
 
3. Results and discussion 
 
3.1. Skin irritability tests 
 
Irritation is deﬁned as the “production of reversible damage to the 
skin following the application of a test substance for up to 4 h,” 
therefore, the more signiﬁcant the initial injury (cell death), the 
stronger the irritant effect (UNECE, 2011). In order to conﬁrm the 
potential of the extracts for topical use, irritability assays with 
EpiSkinTM test were performed. EpiSkinTM is an alternative in vitro 
method efﬁcient in predicting epidermal alterations in vivo caused by 
irritants. Data for the cell viability and the IL-1a release from in vitro 
assays with reconstituted human epidermis are shown in Table 1. 
The method distinguishes between irritants and non-irritants. 
Irritant chemicals are identiﬁed by their ability to decrease cell via- bility 
below deﬁned threshold levels of 50%. The three extracts are not skin 
irritants for topical use in cosmetic formulations as the via- bility in all 
cases is higher than 50%, with values ranging between 
105.9 ± 15.9 and 117.8 ± 9.8. This potential use was also conﬁrmed 
by the low release of IL-1a as endpoint of the irritation process (in the 
range of negative control), which is a highly active and pro- 
inﬂammatory cytokine playing a key role in inﬂammation, being 
produced by keratinocytes. IL-1a is a highly active and pleiotropic pro-
inﬂammatory cytokine that play a key role in inﬂammation, being the 
biological mirror of skin irritation (Balboa et al., 2014). Keratinocytes 
produces IL-1a and IL-1� mRNA in vitro, but only IL- 1a biological activity 
has been identiﬁed in keratinocytes cultures (Mizutani et al., 1991). 
According to Zhang et al. (2011), the con- centration of IL1-a released 
by keratinocytes in cultured medium increased signiﬁcantly follower 
the exposure to different irritants. The IL-1a content, expressed as 
pg/mL, was 28.4 ± 2.6 for PBS, 
522.9 ± 32.1 for SLS, and 8.5 ± 0.1, 76.4 ± 2.0 and 17.6 ± 3.2, respec- 
tively, for aqueous, hydro-alcoholic and alcoholic extract of CS. The 
absence of skin-irritant effects in extracts tested indicated that CS 
extracts could be safe for topical use. 
The morphology alteration that occurs after the contact between the 
extracts and the model was evaluated for all samples and con- trols. 
Fig. 1 shows the effects of hydro-alcoholic extract and controls on the 
morphology of the treated tissues. No morphological dif- ferences 
were observed for the treated tissues with extracts as compared to 
the negative control (PBS). In contrast, the adverse effects observed 
with positive control in all epidermal layers con- ﬁrm the viability 
measurements observed. Results suggest    that 
Signiﬁcant difference (p < 0.05). 
 
 
histological analysis did not assess alterations to the epidermis in 
human skin samples after exposure to CS extracts. 
There are very few reports of irritation potential in skin mod- els 
using extracts as this model was recently validated by ECVAM. Balboa et 
al. (2014) evaluated the in vitro antioxidants properties and the skin 
irritant effects of natural extracts obtained from under- utilized and 
residual vegetal and macroalgal biomass. Extracts did not affect the 
human reconstructed epidermis but the cell via- bility was lower 
than in this study. Regarding the IL-1a release, the irritation process 
seems to be lower. This could be justiﬁed by the different solvents used 
in both studies. Considering the extract composition, reported by 
Rodrigues et al. (2015), it is also expected no effect on skin cells, since the 
identiﬁed compounds did not inter- act with cells, presenting an high 
antioxidant activity and absence of cytotoxicity in keratinocytes and 
ﬁbroblast. Also, washing proce- dures could not remove all materials 
and even lead to mechanical damage to the tissues, which results in an 
impaired prediction of the true skin irritation potential of the 
materials (Molinari et al., 2013). 
 
3.2. Analytical methods 
 
A further part of the  study  was  concerned  with  the analysis  of  
caffeine,  CGA  and  HMF  in  the  medium   after the skin in vitro 
model assay for the three extracts. Chro- matograms of CS extracts 
(A) and standards (B) are depicted in Fig. 2. Compounds were 
numbered according to their elution order. 
HPLC analysis of the CS extracts indicated the presence of caffeine 
and HMF and the absence of CGA for all extracts. The quan- tiﬁcation of 
CAF and HMF is reported in Table 2. 
Caffeine content in CS extracts ranged between 
1.26 ± 0.06 µg/mL and 1.54 ± 0.14 µg/mL for aqueous and hydro- 
alcoholic ones, respectively. There is a statistical difference between 
the caffeine content  of  hydro-alcoholic  extract  and the other 
extracts. As previous mentioned, determination of caffeine in CS is 
very important, since they have a great effect on the ﬁnal quality 
of the extracts used for cosmetic proposes. Previously work done in 
our laboratory, evaluated the CGA content in CS hydro-alcoholic 
extract and results demonstrated the presence of this compound 
(Pereira, 2012). The absence observed in the present study is justiﬁed 
by the retention effect of the epidermal model, which prevents the 
compounds pas- sage. To the best of our knowledge, this is the 
ﬁrst study that reports the content of caffeine after an EpiSkinTM 
assay using extracts. 
 
3.3. Ocular irritability tests 
 
The assessment of ocular irritation is part of the early testing 
procedure for the evaluation of new cosmetic ingredients (Cotovio et 
al., 2010). The use of cosmetic products can produce adverse effects 
on the ocular surface, ranging from mild discomfort to vision-
threatening conditions (Coroneo et al., 2006). These compli- cations can 
be related to allergy or toxicity (Coroneo et al., 2006). 
 
Extract 
 
Viability (%) 
 
IL-1a (pg/mL) 
 Extract HMF (µg/mL extract) CGA (µg/mL 
extract) 
Caffeine (µg/mL 
extract) 
W 117.7 ± 11.7a 8.5 ± 0.1a  W 2.28 ± 0.18 – 1.26 ± 0.06 
WA 105.9 ± 15.9a 76.4 ± 2.0b  WA 2.39 ± 0.27 – 1.54 ± 0.14
*
 
A 117.8 ± 9.8a 17.6 ± 3.2a  A 2.26 ± 0.09 – 1.40 ± 0.07 
  
 
 
 
Fig. 1. Haematoxylin–eosin (HE) staining of the EpiSkinTM tissues. (a) After topical application of 10 µL of hydro-alcoholic extract of CS: no irritation signs. (b) Negative control (100% cell 
viability): no irritation signs. (c) Positive control (5% SDS): marked epidermolysis. 
 
In this ﬁeld, numerous non-animal test systems have been devel- oped 
over the years (OECD, 2009a,b). SkinEthicTM HCE is one of the two 
reconstructed human tissue that are currently available for the purpose 
of eye irritation and is under validation by ECVAM (Alépée et al., 2013). 
In order to evaluate the eye irritation potential of CS extracts, a 
SkinEthicTM HCE test was done. Table 3 summarizes the results for cell 
viability and release of IL-1a observed with extracts and controls. 
The viability of cells with aqueous and hydro-alcoholic extracts were  
higher  than  50%,  with  percentages  of  132.6 ± 21.3  and 
123.6 ± 13.7, respectively, which means that the extracts were 
classiﬁed as non-irritants for the eyes. Ethanolic extract presented a 
percentage of viability of 48.0 ± 7.5, being in the borderline 
between irritant and non irritant, which is justify by the higher 
amount of alcohol used. Regarding the IL-1a release, no signiﬁcant 
differences were observed between negative control and aqueous or 
hydro-alcoholic extracts. However, the release of IL-1a slightly 
 
 
 
 
Fig. 2. Chromatograms of aqueous extract (a), hydro-alcoholic extract (b) and alcoholic extract (c) of CS and a standard mixture (1 mg/mL) (d) of HMF (1), CQA (2) and caffeine  (3). 
  
 
 
 
Fig. 4. Frequency of clinical scores attributed to positive control (PC – SLS), nega- tive 
control (NC – puriﬁed water) and hydro-alcoholic extract of CS (HA) regarding erythema 
and oedema after patch removal. * means a signiﬁcant difference (p < 0.05). 
 
Fig. 3. Haematoxylin–eosin (HE) staining of the SkinEthicTM HCE tissues. After top- ical 
application of 10 µL of alcoholic (a) extract of CS: irritation signals. (b) Negative control 
(100% cell viability): no irritation signs. (c) Positive control (5% SLS): marked epidermolysis. 
 
increased when using the positive control and ethanol extract as 
compared to the negative control. As mentioned by manufacture, 
ethanol was used as negative control. 
The histological images obtained after topical application of the 
aqueous and hydro-alcoholic extracts of CS also conﬁrms that both are 
not irritant, being good candidates for cosmetic ingredients. 
Regarding alcoholic extract, results are very different. As it is pos- sible 
to conﬁrm, this extract leads to histological alterations in 
SkinEthicTM HCE tissues, similarly to positive control (Fig. 3). 
As far as we know, this is also the ﬁrst time that SkinEthicsTM 
HCE is used to evaluate the ocular irritation for food by-products 
extracts in order to incorporate them in cosmetics as active 
ingredients. 
 
3.4. In vivo test 
 
According to Miles et al. (2014), reconstructed human epider- mis 
like EpiSkinTM has some limitations. This model is composed 
 
Table 3 
SkinEthicTM HCE model was exposed for 10 min to controls and extracts. Cell viability was 
assessed by MTT while the post-exposure basal media was analysed for IL-1a release 
(pg/mL). 
 
 
Extract Viability (%) IL-1a (pg/mL) 
 
W 132.6 ± 21.3a 41.4  ± 2.5a 
WA 123.6 ± 13.7a 34.2  ± 1.6a 
A 48.0  ± 7.5b 82.2 ± 22.9b 
PC (ethanol) 2.9 ± 0.5c 114.4 ± 2.5c 
NC (PBS) 86.0 ± 6.1d 23.7  ± 1.0a 
Water (W), hydro-alcoholic (WA) mixture, alcohol (A), a positive control (PC) and a 
negative control (NC: PBS – phosphate buffered saline) were used. Values are 
expressed as mean ± SD (n = 3). Values in the same column followed by different letters 
indicate signiﬁcant differences (p < 0.05). 
 
of a highly differentiated multi-layer human epidermis cells, but are 
totally lacking in any network of the pilo-sebaceous units, which 
regulate dermal homeostasis (Miles et al., 2014). Also, the hydrolipid 
ﬁlm cannot be totally reproduced regarding its bio- physiological 
properties of components (urea, glycolic acid) neither to the occlusive 
effect of the ﬁlm’s lipid component (ceramides) (Miles et al., 2014). 
Some cells normally present in human skin are not present in this 
model such as dendritic Langerhans’ cells. The higher penetration rate 
of these tissues makes these skin models more sensitive to test 
compounds (Perkins et al., 1999), which could result in over-prediction 
of strong irritants (Welss et al., 2004). Thus, to ensure that the 
extract is completely safe, some other assays like patch test should 
be done. Patch testing after a single application is a widely used 
procedure to evaluate acute irritant reactions in human volunteers. 
The previous assays led us to select the hydro-alcoholic extract as 
the best one to be incorporated in cosmetic products, as it did not 
affect the morphology of skin and ocular models, with high cell viability 
for both assays and low IL-1a release. Also the CAF con- tent was 
higher than in the other extracts evaluated and, according to Rodrigues 
et al. (2015), the antioxidant content and antimi- crobial activity is 
higher. Considering not only these results but also sustainability 
questions and other previous works regarding the antioxidant activity 
of these extracts, hydro-alcoholic extract seems to be the best one, 
being selected for the ﬁnal patch test (Bresciani et al., 2014; Costa et 
al., 2014; Narita and Inouye, 2012). 
 
3.4.1. Skin compatibility by evaluation of primary skin irritation 
Initially, evaluation of irritancy testing was based on visual 
score. Results obtained by visual analyse are shown in Fig. 4. Results of 
patch testing demonstrated that hydro-alcoholic provoked a slight 
erythema in three volunteers 2 h after the patch test removal, however, 
when statistical analyses were applied regarding negative control, no 
differences were found. Regarding the positive control, it is possible to 
observe statistical differences when comparing with negative control 
and hydro-alcoholic extract (p < 0.05). 
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Fig. 5. Transepidermal water loss (TEWL) variation from basal values of negative control 
(NC), positive control (PC) and hydro-alcoholic extract (HA). The left boxes represent 
values at time 0 and the right boxes represent values 2 h after patch removal. 
Outliers are presented as circles. * means a signiﬁcant difference (p < 0.05). 
 
3.4.2. Transepidermal water loss variation 
The measurement of transepidermal water loss (TEWL) is a well- 
established method in dermatology to assess the integrity of the skin 
barrier in vivo and an important measure of epidermal barrier function 
(Pinnagoda et al., 1990). When skin is damaged, the barrier function is 
impaired which results in a higher water loss. The extract did not alter the 
skin barrier function, as TEWL values were not changed, when 
compared to the positive control (Fig. 5). 
No signiﬁcant differences were observed for TEWL measure- 
ments, in comparison with puriﬁed water, 2 h after patch removal (p < 
0.05), which indicates the absence of barrier disruption. Con- 
sequently, CS hydro-alcoholic extract is not potentially irritating. The 
only effect on TEWL values was probably due to the even- tual 
formation of a greasy ﬁlm by the lipophilic components of the extract. 
Comparing with other extracts that are under investiga- tion, CS could 
be consider as safe for cosmetic purposes (Almeida et al., 2008; 
Dal’Belo et al., 2006). Unlike arnica and Calendula ofﬁc- inalis, CS did 
not originate skin irritation (Reider et al., 2001). As expected, SLS (PC) 
leads to an increase of TEWL values. 
 
4. Conclusion 
 
This study constitutes an objective evaluation of the safety of CS 
extract as cosmetic ingredient and contributes to the elucidation of its 
mechanism of action. It is an overview of the effect of CS extracts in a 
validated human skin model for irritancy and eye model under 
validation. In vitro studies on ocular and dermal irritation were car- ried 
out with three different extracts of CS. The in vivo study was carried 
out with the extract that revealed the best results for the in vitro 
assays. Results of in vitro studies revealed that CS extracts are safe 
regarding to skin and ocular irritancy as cell viability was equal to the 
negative control in both assays and the IL-1a was under 50%. The 
histological analysis demonstrated that extracts did not affect the skin 
neither the ocular model. Quantitative chromato- graphic 
investigations revealed that the three extracts contained caffeine and 
HMF, but there were no traces of CGA. The in vivo patch tests proved that 
the hydro-alcoholic extract did not cause skin irri- tation. The next steps 
to evaluate the safety of the extract would undergo sensitization and 
tolerance studies in normal condition of use. 
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